Does Insurance Cover Wegovy? (2026 Coverage Guide)

Step 1: Check your formulary

Every insurance plan publishes a "formulary" — the list of covered drugs. Look for "Wegovy" specifically, and note the tier (usually Tier 3 or specialty). If Wegovy isn't listed, look for the category "anti-obesity medications" or "weight-management" — some plans exclude the whole category.

Fastest way to check: log into your insurer's member portal, search "Wegovy," and screenshot the result. Or call the member services number on your card and ask "Is Wegovy on my formulary, and what's the copay?"

Step 2: Understand the prior authorization

Even when Wegovy is on your formulary, plans almost always require prior authorization (PA). Typical PA requirements:

• BMI ≥30, or BMI ≥27 with a comorbidity (hypertension, T2D, dyslipidemia, obstructive sleep apnea)
• Documentation of at least 3–6 months of a supervised weight-loss attempt via diet and exercise
• No history of medullary thyroid carcinoma or MEN 2
• Not pregnant

Your clinician submits the PA. Approval typically takes 3–10 business days.

Medicare and Wegovy

Historically, Medicare Part D was barred from covering weight-loss drugs. That changed in 2024 when the FDA approved Wegovy for cardiovascular risk reduction in adults with obesity and established heart disease (SELECT trial). Under that new indication, Medicare Part D can cover Wegovy — but only for patients who meet the CV indication, not for weight loss alone. Check with your specific Part D plan.

Medicaid and Wegovy

Coverage is state-by-state. States like California, Michigan, and Pennsylvania cover Wegovy under specific criteria; others exclude anti-obesity medications entirely. Your state's Medicaid preferred drug list (PDL) is the source of truth.

Employer plans: what to know

If you have employer-sponsored insurance, coverage depends on what plan design your employer chose. Many self-insured employers exclude the anti-obesity medications category to control cost. HR is the ultimate arbiter — some large employers added Wegovy coverage in 2024–2025 after the SELECT results shifted the conversation from cosmetic weight loss to cardiovascular protection.

What to do when it's denied

1. Read the denial letter carefully. The specific reason (missing documentation, doesn't meet BMI criteria, plan exclusion) determines your next step.
2. File a formal appeal. Your clinician can submit a letter of medical necessity with documented BMI, comorbidities, prior failed lifestyle interventions, and citations to SELECT (if CV risk applies).
3. Request a peer-to-peer review. Your clinician calls the insurance company's medical director directly. Approvals often come out of these.
4. File an external appeal. If internal appeals fail, most states let you request an independent external review at no cost.

Manufacturer help while you fight coverage

The Novo Nordisk savings card can reduce commercially insured copays to as low as $0 for eligible patients (up to a $200/month benefit). It doesn't work if your plan doesn't cover Wegovy — for uncovered commercial patients, NovoCare offers Wegovy vials for ~$499/month direct.

Cash-pay if you give up on insurance

• NovoCare direct: ~$499/month for single-dose vials
• Compounded semaglutide via telehealth: $150–$400/month, legal only under narrow medical-necessity criteria
• Zepbound instead: LillyDirect vials at $349–$499/month — often the cheapest brand-name path

FAQ